Static

Sequoia, Greenoaks Lead Isomorphic Lab’s $5 Billion Funding Round

First reported by Bloomberg ·

The signal ●○○○ Compiled by AI from Bloomberg, the single source so far
Why you might care

If you develop drugs using AI, the tools you use will get materially better.

What happened

Isomorphic Labs raised $5 billion in a funding round led by Sequoia and Greenoaks, six months after its previous announcement.

What it means

Based on limited preview — the full article may require a subscription

Isomorphic Labs, an Alphabet subsidiary focused on AI drug discovery, secured a significant $5 billion in funding. This substantial investment underscores continued confidence in AI's potential to revolutionize pharmaceutical research and development, suggesting accelerated progress in the field.

AI-written summary. May contain errors.

Funding